Gornitzky represented JonesTrading Institutional Services as the exclusive placement agent in the USD 6 million registered direct offering of American Depositary Shares (ADSs) and warrants of BioLineRx Ltd. BioLineRx is a commercial-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases. BioLineRx is dually listed with its ADSs and ordinary shares traded on Nasdaq and the Tel Aviv Stock Exchange, respectively.
Jones Trading were represented by partners Chaim Friedland, Ari Fried and Dr. Assaf Prussak, along with associate Mike Hanukovich.
